AGNARGENICA THERAPEUTICS LIMITEDMarket sensitive

Topline Phase 2 Trial Results of ARG-007 in AIS Patients

Date and time
Announcement type
Company Update

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case